Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.
暂无分享，去创建一个
S. Zhang | Ying Tang | Shi Hu | Wenyan Fu | Yong-Ji Yang | Qing-ning Yuan | Ya-feng Shen | Changhai Lei | Xiaoyan Fan | Tian Li | Fangxing Lin | Min Ding | X. Ye | Yuanyuan Lv | Gaojian Lv | Feifei Wang | Haibin Dai | Ruo-bing Jin